Literature DB >> 20410349

Impact of Pseudomonas aeruginosa genomic instability on the application of typing methods for chronic cystic fibrosis infections.

Joanne L Fothergill1, Judith White, Juliet E Foweraker, Martin J Walshaw, Martin J Ledson, Eshwar Mahenthiralingam, Craig Winstanley.   

Abstract

The Liverpool epidemic strain (LES) of Pseudomonas aeruginosa is widespread among cystic fibrosis (CF) patients in the United Kingdom and has emerged recently in North America. In this study, we report the analysis of 24 "anomalous" CF isolates of P. aeruginosa that produced inconsistent results with regard to either pulsed-field gel electrophoresis (PFGE) or PCR tests for the LES. We used a new typing method, the ArrayTube genotyping system, to determine that of the 24 anomalous isolates tested, 13 were confirmed as the LES. LES isolates could not be clearly distinguished from non-LES isolates by two other commonly used genetic fingerprinting tests, randomly amplified polymorphic DNA (RAPD) analysis and BOX-PCR, and varied considerably in their carriage of LES genomic islands and prophages. The genomic instability of the LES suggests that identification of this emerging transmissible strain could be a challenging task, and it questions whether discrimination is always a desirable feature of bacterial typing methods in the context of chronic CF infections.

Entities:  

Mesh:

Year:  2010        PMID: 20410349      PMCID: PMC2884492          DOI: 10.1128/JCM.00019-10

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  38 in total

1.  Achieving 100% typeability of Pseudomonas aeruginosa by pulsed-field gel electrophoresis.

Authors:  U Römling; B Tümmler
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

2.  Identification of type II and type III pyoverdine receptors from Pseudomonas aeruginosa.

Authors:  Magaly de Chial; Bart Ghysels; Scott A Beatson; Valérie Geoffroy; Jean Marie Meyer; Theresa Pattery; Christine Baysse; Patrice Chablain; Yasmin N Parsons; Craig Winstanley; Stuart J Cordwell; Pierre Cornelis
Journal:  Microbiology (Reading)       Date:  2003-04       Impact factor: 2.777

3.  Spread of an epidemic Pseudomonas aeruginosa strain from a patient with cystic fibrosis (CF) to non-CF relatives.

Authors:  S J McCallum; M J Gallagher; J E Corkill; C A Hart; M J Ledson; M J Walshaw
Journal:  Thorax       Date:  2002-06       Impact factor: 9.139

4.  Superinfection with a transmissible strain of Pseudomonas aeruginosa in adults with cystic fibrosis chronically colonised by P aeruginosa.

Authors:  S J McCallum; J Corkill; M Gallagher; M J Ledson; C A Hart; M J Walshaw
Journal:  Lancet       Date:  2001-08-18       Impact factor: 79.321

Review 5.  Persistent and aggressive bacteria in the lungs of cystic fibrosis children.

Authors:  C Anthony Hart; Craig Winstanley
Journal:  Br Med Bull       Date:  2002       Impact factor: 4.291

6.  Use of subtractive hybridization to identify a diagnostic probe for a cystic fibrosis epidemic strain of Pseudomonas aeruginosa.

Authors:  Yasmin N Parsons; Stavroula Panagea; Catherine H M Smart; Martin J Walshaw; C Anthony Hart; Craig Winstanley
Journal:  J Clin Microbiol       Date:  2002-12       Impact factor: 5.948

7.  Characterization of a Shiga toxin-encoding temperate bacteriophage of Shigella sonnei.

Authors:  E Strauch; R Lurz; L Beutin
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

8.  Comparative assessment of genotyping methods for epidemiologic study of Burkholderia cepacia genomovar III.

Authors:  Tom Coenye; Theodore Spilker; Alissa Martin; John J LiPuma
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

9.  Epidemiology of Pseudomonas aeruginosa in cystic fibrosis in British Columbia, Canada.

Authors:  David P Speert; Maureen E Campbell; Deborah A Henry; Ruth Milner; Fatma Taha; Anna Gravelle; A George F Davidson; Lawrence T K Wong; Eshwar Mahenthiralingam
Journal:  Am J Respir Crit Care Med       Date:  2002-10-01       Impact factor: 21.405

10.  Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis.

Authors:  Julia Emerson; Margaret Rosenfeld; Sharon McNamara; Bonnie Ramsey; Ronald L Gibson
Journal:  Pediatr Pulmonol       Date:  2002-08
View more
  14 in total

1.  Sequential Treatment of Biofilms with Aztreonam and Tobramycin Is a Novel Strategy for Combating Pseudomonas aeruginosa Chronic Respiratory Infections.

Authors:  Estrella Rojo-Molinero; María D Macià; Rosa Rubio; Bartolomé Moyà; Gabriel Cabot; Carla López-Causapé; José L Pérez; Rafael Cantón; Antonio Oliver
Journal:  Antimicrob Agents Chemother       Date:  2016-04-22       Impact factor: 5.191

Review 2.  Epidemiology, Biology, and Impact of Clonal Pseudomonas aeruginosa Infections in Cystic Fibrosis.

Authors:  Michael D Parkins; Ranjani Somayaji; Valerie J Waters
Journal:  Clin Microbiol Rev       Date:  2018-08-29       Impact factor: 26.132

3.  Comparison of three molecular techniques for typing Pseudomonas aeruginosa isolates in sputum samples from patients with cystic fibrosis.

Authors:  Timothy J Kidd; Keith Grimwood; Kay A Ramsay; Paul B Rainey; Scott C Bell
Journal:  J Clin Microbiol       Date:  2010-11-17       Impact factor: 5.948

4.  Comparison of three typing methods for Pseudomonas aeruginosa isolates from patients with cystic fibrosis.

Authors:  V Waters; J E A Zlosnik; Y C W Yau; D P Speert; S D Aaron; D S Guttman
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-07-29       Impact factor: 3.267

5.  Pseudomonas aeruginosa isolates from dental unit waterlines can be divided in two distinct groups, including one displaying phenotypes similar to isolates from cystic fibrosis patients.

Authors:  Myriam M Ouellet; Annie Leduc; Christine Nadeau; Jean Barbeau; Steve J Charette
Journal:  Front Microbiol       Date:  2015-01-21       Impact factor: 5.640

6.  Clinical utilization of genomics data produced by the international Pseudomonas aeruginosa consortium.

Authors:  Luca Freschi; Julie Jeukens; Irena Kukavica-Ibrulj; Brian Boyle; Marie-Josée Dupont; Jérôme Laroche; Stéphane Larose; Halim Maaroufi; Joanne L Fothergill; Matthew Moore; Geoffrey L Winsor; Shawn D Aaron; Jean Barbeau; Scott C Bell; Jane L Burns; Miguel Camara; André Cantin; Steve J Charette; Ken Dewar; Éric Déziel; Keith Grimwood; Robert E W Hancock; Joe J Harrison; Stephan Heeb; Lars Jelsbak; Baofeng Jia; Dervla T Kenna; Timothy J Kidd; Jens Klockgether; Joseph S Lam; Iain L Lamont; Shawn Lewenza; Nick Loman; François Malouin; Jim Manos; Andrew G McArthur; Josie McKeown; Julie Milot; Hardeep Naghra; Dao Nguyen; Sheldon K Pereira; Gabriel G Perron; Jean-Paul Pirnay; Paul B Rainey; Simon Rousseau; Pedro M Santos; Anne Stephenson; Véronique Taylor; Jane F Turton; Nicholas Waglechner; Paul Williams; Sandra W Thrane; Gerard D Wright; Fiona S L Brinkman; Nicholas P Tucker; Burkhard Tümmler; Craig Winstanley; Roger C Levesque
Journal:  Front Microbiol       Date:  2015-09-29       Impact factor: 5.640

7.  "Pathogen Eradication" and "Emerging Pathogens": Difficult Definitions in Cystic Fibrosis.

Authors:  Peter H Gilligan; Damian G Downey; J Stuart Elborn; Patrick A Flume; Sebastian Funk; Deirdre Gilpin; Timothy J Kidd; John McCaughan; B Cherie Millar; Philip G Murphy; Jacqueline C Rendall; Michael M Tunney; John E Moore
Journal:  J Clin Microbiol       Date:  2018-08-27       Impact factor: 5.948

8.  Differential infection properties of three inducible prophages from an epidemic strain of Pseudomonas aeruginosa.

Authors:  Chloe E James; Joanne L Fothergill; Amanda J Hall; Jennifer Cottell; Michael A Brockhurst; Craig Winstanley
Journal:  BMC Microbiol       Date:  2012-09-21       Impact factor: 3.605

9.  Molecular typing and epidemiological investigation of clinical populations of Pseudomonas aeruginosa using an oligonucleotide-microarray.

Authors:  Annalisa Ballarini; Giovanna Scalet; Malgorzata Kos; Nina Cramer; Lutz Wiehlmann; Olivier Jousson
Journal:  BMC Microbiol       Date:  2012-07-27       Impact factor: 3.605

10.  Sub-inhibitory concentrations of some antibiotics can drive diversification of Pseudomonas aeruginosa populations in artificial sputum medium.

Authors:  Elli A Wright; Joanne L Fothergill; Steve Paterson; Michael A Brockhurst; Craig Winstanley
Journal:  BMC Microbiol       Date:  2013-07-23       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.